Invesaro

Stocks BNZI Financial statements

Financial statements

Banzai International, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Banzai International, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2022FY2023FY2024FY2025
Revenue5.334.564.5312.2
Cost of revenue1.961.441.422.19
Gross profit3.383.123.119.97
General and administrative2.489.2812.916.527.3
Operating expenses9.5912.916.628.4
Operating income-2.68-6.21-9.8-13.5-18.5
Interest income0.020000
Other non-operating income-9.26-4.61-18-3.97
Pre-tax income11.6-15.5-14.4-31.5-22.4
Income tax0000.06
Net income11.6-15.5-14.4-31.5-22.5
EBITDA-6.2-9.79-13.4-17.3
EPS, basic-68.62-60.04-69.75-5.95
EPS, diluted-68.62-60.04-69.75-5.95
Shares, basic (weighted)0.230.240.453.78
Shares, diluted (weighted)0.230.240.453.78

Balance sheet

FY2021FY2022FY2023FY2024FY2025
Cash and equivalents0.711.022.091.090.26
Receivables0.070.070.110.940.71
Other current assets0.260.040.070.050
Total current assets0.981.432.942.671.41
Property, plant and equipment0.01000.01
Lease right-of-use assets0.310.130.070.06
Goodwill2.172.172.171922
Intangible assets03.888.03
Total assets2315.485.2925.731.6
Accounts payable0.341.16.447.782.49
Accrued liabilities11.76
Deferred revenue0.931.213.933.64
Total current liabilities1.5229.337.128.322.4
Lease liabilities0.2300.050.03
Other non-current liabilities0.080.080
Total liabilities21.129.637.228.423.6
Paid-in capital08.2514.975.5109
Retained earnings-20.1-32.4-46.8-78.3-101
Other comprehensive income0-0.09
Shareholders' equity-15.7-24.1-31.9-2.768.06
Total equity-15.7-24.1-31.9-2.768.06
Total liabilities and equity2315.485.2925.731.6
Shares outstanding5.750.230.260.820.53

Cash flow statement

FY2021FY2022FY2023FY2024FY2025
Net income11.6-15.5-14.4-31.5-22.5
Depreciation and amortization0.010.010.021.15
Stock-based compensation0.771.251.172.68
Deferred income tax-0.15
Change in receivables-0.090.070.020.21
Change in payables0.330.665.341.01-0.38
Cash from operations-1.01-5.17-1.55-9.58-15.7
Capital expenditures-0.010
Acquisitions00.080
Cash from investing0-0.0100.08-2.68
Stock issued0.010.036.26
Cash from financing04.422.628.4917.6
Exchange rate effect0-0.08
Net change in cash-1.01-0.761.07-1.01-0.83
Free cash flow-5.18-1.55
Interest paid0.630.960.341.1
Income taxes paid-00.010.010.01

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.91 on August 6, 2026.

Profitability

MetricValueHow it is calculated
Gross margin81.2%Gross profit / revenue.
Operating margin-177.7%Operating income / revenue.
EBITDA margin-166.3%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-227.9%Pre-tax income / revenue.
Net margin-228.7%Net income / revenue.
Operating cash flow margin-151.1%Cash from operations / revenue.
Return on equity (ROE)-198.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-77.6%Net income / average total assets.
Return on invested capital (ROIC)-128.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue38.3%Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue11.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y168.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y31.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y221.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y43.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y23.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y79.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y748.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y156.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.10xCurrent assets / current liabilities.
Quick ratio0.06x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.04x(Cash + short-term investments) / current liabilities.
Liabilities / assets60.9%Total liabilities / total assets.
Working capital-$16.2MCurrent assets - current liabilities.
Goodwill and intangibles / assets94.0%(Goodwill + intangible assets) / total assets.
Tangible book value-$17.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.34xRevenue / average total assets.
Receivables turnover26.6xRevenue / average receivables.
Days sales outstanding14 days365 x average receivables / revenue.
Days payables450 days365 x average accounts payable / cost of revenue.

Per share

MetricValueHow it is calculated
EPS, diluted-$14.94Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$6.53Revenue / diluted weighted shares.
Operating cash flow per share-$9.86Cash from operations / diluted weighted shares.
Book value per share$4.55Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$6.39Tangible book value / shares outstanding.
Cash per share$0.24(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$5.1MShare price x shares outstanding.
Enterprise value$4.5MMarket cap + total debt - cash - short-term investments.
P/S0.48xMarket cap / revenue.
P/B0.42xMarket cap / shareholders' equity. Only when equity is positive.
EV/Sales0.42xEnterprise value / revenue.
Earnings yield-472.9%Net income / market cap (the inverse of P/E).
What was Banzai International, Inc.'s revenue in fiscal 2025?

Banzai International, Inc. reported revenue of $12.2M for fiscal 2025, 168.6% higher than the year before.

Was Banzai International, Inc. profitable in fiscal 2025?

No. It reported a net loss of $22.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Banzai International, Inc.